Drug interactions between linezolid and selective serotonin reuptake inhibitors: Case report involving sertraline and review of the literature

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 269-276

  Clark, Deidre B ^a   Andrus, Miranda R ^b,c   Byrd, Debbie C ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b AUBURN UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Drug interaction; Linezolid; Selective serotonin reuptake inhibitor; Serotonin syndrome; Sertraline; SSRI

Indexed keywords

ALPRAZOLAM; ATENOLOL; BENZONATATE; CALCIUM; CHLORAMPHENICOL; CITALOPRAM; CLONAZEPAM; CLOPIDOGREL; CORTICOSTEROID; CYPROHEPTADINE; ERYTHROPOIETIN; ESCITALOPRAM; FAMOTIDINE; FLUOXETINE; FOSINOPRIL; GABAPENTIN; GENTAMICIN; INSULIN; LINEZOLID; MONOAMINE OXIDASE INHIBITOR; NATEGLINIDE; PAROXETINE; PIOGLITAZONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIMVASTATIN; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG; VANCOMYCIN;

ADULT; BACTERIAL INFECTION; CARDIOPULMONARY ARREST; CASE REPORT; CLINICAL FEATURE; COMA; CONFUSION; COORDINATION DISORDER; DEPRESSION; DIARRHEA; DRUG FEVER; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MYOCLONUS; PATIENT MONITORING; RETROSPECTIVE STUDY; REVIEW; SEROTONIN SYNDROME; SYSTEMATIC REVIEW; TACHYCARDIA; TREMOR;

ACETAMIDES; AMPUTATION STUMPS; ANTI-BACTERIAL AGENTS; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; GANGRENE; HUMANS; MIDDLE AGED; NEUROTOXICITY SYNDROMES; OXAZOLIDINONES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SURGICAL WOUND INFECTION;

EID: 32044443633     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.269     Document Type: Review

References (21)

1. Eli Lilly and Company. Prozac (fluoxetine hydrochloride) package insert. Indianapolis, IN; 2005.
2. Pfizer Inc. Zoloft (sertraline hydrochloride) package insert. New York, NY; 2003.
3. GlaxoSmithKline. Paxil (paroxetine hydrochloride) package insert. Research Triangle Park, NC; 2005.
4. Forest Pharmaceuticals, Inc. Celexa (citalopram hydrobromide) package insert. St. Louis, MO; 2005.
5. Forest Pharmaceuticals, Inc. Lexapro (escitalopram oxalate) package insert. St. Louis, MO; 2005.
6. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. Can Med Assoc J 2003;168:1439-42.
7. Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med 2003;4:63-74.
8. Sternbach H. The Serotonin syndrome. Am J Psychiatry 1991;148:705-13.
9. Sternbach H. Serotonin syndrome: how to avoid, identify, and treat dangerous drug interactions [online exclusive article]. Curr Psychiatry Online 2003;2:5. Available from www.currentpsychiatrycom/2003_05/0503_serotonin.asp.
10. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
11. Lavery S, Ravi H, McDaniel WW, Pushkin YR. Linezolid and serotonin syndrome. Psychomatics 2001;42:432-4.
12. Hachem RY, Hicks K, Huen A, Raad I. Myelosuppression and Serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients [online exclusive article]. Clin Infect Dis 2003;37:e8-11. Available from http://www.journals. uchicago. edu/CID/journal/issues/v37n1/30291/30291.html.
13. Wigen CL, Goetz WB. Serotonin syndrome and linezolid. Clin Infect Dis 2003;34:1651-2.
14. Bernard L, Stern R, Hoffmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003;36:1197.
15. Tahir N. Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram. J Am Med Dir Assoc 2004;5:111-13.
16. Bergeron L, Boule M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother 2005;39:956-61.
17. Thomas CR, Rosenberg M, Blythe V, Meyer WJ. Serotonin syndrome and linezolid [letter]. J Am Acad Child Adolesc Psychiatry 2004;43:790.
18. Morales N, Vermette H. Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine [letter]. Psychosomatics 2005;46:274-5.
19. Leach TS, Lobeck FG, Todd WM, Hafkin B. Lack of serotonin syndrome in phase III patients receiving linezolid and a selective serotonin reuptake inhibitor [abstr]. Clin Infect Dis 2003;31:224.
20. Sorbello A, Wassel R, Soreth J, Nambiar S. Post-marketing reports of serotonin syndrome associated with linezolid [abstr]. U.S. Food and Drug Administration Science Forum poster abstract H-PO-37 2005. Available from www.cfsan.fda.gov/~frf/forum05/H-PO-37.htm. Accessed August 24, 2005.
21. Jones SL, Athan E, O'Brien D. Serotonin syndrome due to co-administration of linezolid and venlafaxine. J Antimicrob Chemother 2004;54:289-90.